The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 30, 2026 | Evans Daron | CFO | Buy(P) | 10K | $2.85 | $29K |
| Mar 2, 2026 | Elam Nevan C | CEO, Director | Tax withholding(F) | 28K | $2.99 | $83K |
| Mar 2, 2026 | Evans Daron | CFO | Tax withholding(F) | 11K | $2.99 | $34K |
| Mar 2, 2026 | Roberts Brian Kenneth | Chief Medical Officer | Tax withholding(F) | 11K | $2.99 | $34K |
| Dec 16, 2025 | Roberts Brian Kenneth | Chief Medical Officer | Buy(P) | 28K | $1.70 | $48K |
| Dec 16, 2025 | Hogenhuis Wladimir | Director | Buy(P) | 6K | $1.69 | $10K |
| Dec 15, 2025 | Karnawat Sunil Ratilal | Chief Commercial Officer | Buy(P) | 100 | $1.60 | $160 |
| Dec 15, 2025 | Karnawat Sunil Ratilal | Chief Commercial Officer | Buy(P) | 12K | $1.62 | $19K |
| Dec 15, 2025 | Elam Nevan C | CEO, Director | Buy(P) | 32K | $1.59 | $51K |
| Dec 15, 2025 | Evans Daron | CFO | Buy(P) | 40K | $1.77 | $71K |
| Dec 15, 2025 | Evans Daron | CFO | Buy(P) | 3K | $1.79 | $4K |
| Dec 15, 2025 | Evans Daron | CFO | Buy(P) | 3K | $1.79 | $4K |
| Nov 19, 2025 | Labrucherie Gil M | Director | Grant(A) | 21K | — | $0 |
| Nov 19, 2025 | Labrucherie Gil M | Director | Grant(A) | 12K | — | $0 |
| Nov 19, 2025 | Fauchet Philippe | Director | Grant(A) | 21K | — | $0 |
| Nov 19, 2025 | Fauchet Philippe | Director | Grant(A) | 12K | — | $0 |
| Nov 19, 2025 | Kim Young-Jin | Director | Grant(A) | 21K | — | $0 |
| Nov 19, 2025 | Kim Young-Jin | Director | Grant(A) | 12K | — | $0 |
| Nov 19, 2025 | Harris Erik | Director | Grant(A) | 21K | — | $0 |
| Nov 19, 2025 | Harris Erik | Director | Grant(A) | 12K | — | $0 |
| Nov 19, 2025 | Hogenhuis Wladimir | Director | Grant(A) | 21K | — | $0 |
| Nov 19, 2025 | Hogenhuis Wladimir | Director | Grant(A) | 12K | — | $0 |
| Nov 19, 2025 | Kreher Nerissa | Director | Grant(A) | 21K | — | $0 |
| Nov 19, 2025 | Kreher Nerissa | Director | Grant(A) | 12K | — | $0 |
| Nov 19, 2025 | Evans Daron | CFO | Grant(A) | 107K | — | $0 |
| Nov 19, 2025 | Evans Daron | CFO | Grant(A) | 63K | — | $0 |
| Nov 19, 2025 | Elam Nevan C | CEO, Director | Grant(A) | 317K | — | $0 |
| Nov 19, 2025 | Elam Nevan C | CEO, Director | Grant(A) | 186K | — | $0 |
| Nov 19, 2025 | Karnawat Sunil Ratilal | Chief Commercial Officer | Grant(A) | 32K | — | $0 |
| Nov 19, 2025 | Karnawat Sunil Ratilal | Chief Commercial Officer | Grant(A) | 19K | — | $0 |
| Nov 19, 2025 | Roberts Brian Kenneth | Chief Medical Officer | Grant(A) | 123K | — | $0 |
| Nov 19, 2025 | Roberts Brian Kenneth | Chief Medical Officer | acquired() | 72K | — | $0 |
| Aug 18, 2025 | Karnawat Sunil Ratilal | Chief Commercial Officer | Grant(A) | 25K | — | $0 |
| Aug 18, 2025 | Karnawat Sunil Ratilal | Chief Commercial Officer | Grant(A) | 275K | — | $0 |
| Jun 25, 2025 | Roberts Brian Kenneth | Chief Medical Officer | Buy(P) | 3K | $4.38 | $11K |
| Jun 24, 2025 | Evans Daron | CFO | Buy(P) | 5K | $4.05 | $20K |
| Jun 13, 2025 | Kreher Nerissa | Director | Buy(P) | 3K | $3.25 | $10K |
| Jun 13, 2025 | Kim Young-Jin | Director | Buy(P) | 1.2M | $3.25 | $4.0M |
| Jun 10, 2025 | Elam Nevan C | CEO, Director | Grant(A) | 68K | — | $0 |
| Jun 10, 2025 | Elam Nevan C | CEO, Director | Grant(A) | 40K | — | $0 |
| Jun 10, 2025 | Roberts Brian Kenneth | Chief Medical Officer | Grant(A) | 26K | — | $0 |
| Jun 10, 2025 | Roberts Brian Kenneth | Chief Medical Officer | Grant(A) | 15K | — | $0 |
| Jun 10, 2025 | Fauchet Philippe | Director | Grant(A) | 9K | — | $0 |
| Jun 10, 2025 | Fauchet Philippe | Director | Grant(A) | 5K | — | $0 |
| Jun 10, 2025 | Evans Daron | CFO | Grant(A) | 26K | — | $0 |
| Jun 10, 2025 | Evans Daron | CFO | Grant(A) | 15K | — | $0 |
| Jun 10, 2025 | Kim Young-Jin | Director | Grant(A) | 9K | — | $0 |
| Jun 10, 2025 | Kim Young-Jin | Director | Grant(A) | 5K | — | $0 |
| Jun 10, 2025 | Hogenhuis Wladimir | Director | Grant(A) | 9K | — | $0 |
| Jun 10, 2025 | Hogenhuis Wladimir | Director | Grant(A) | 5K | — | $0 |
| Jun 10, 2025 | Labrucherie Gil M | Director | Grant(A) | 9K | — | $0 |
| Jun 10, 2025 | Labrucherie Gil M | Director | Grant(A) | 5K | — | $0 |
| Jun 10, 2025 | Kreher Nerissa | Director | Grant(A) | 9K | — | $0 |
| Jun 10, 2025 | Kreher Nerissa | Director | Grant(A) | 5K | — | $0 |
| Mar 31, 2025 | Hogenhuis Wladimir | Director | Buy(P) | 7K | $2.92 | $20K |
| Mar 27, 2025 | Elam Nevan C | CEO, Director | Buy(P) | 12K | $2.85 | $35K |
| Mar 26, 2025 | Evans Daron | CFO | Buy(P) | 10K | $2.89 | $29K |
| Mar 26, 2025 | Evans Daron | CFO | Buy(P) | 10K | $2.88 | $29K |
| Mar 25, 2025 | Harris Erik | Director | Grant(A) | 60K | — | $0 |
| Feb 18, 2025 | Hogenhuis Wladimir | Director | Buy(P) | 10K | $4.70 | $47K |
| Feb 16, 2025 | Fauchet Philippe | Director | Grant(A) | 26K | — | $0 |
| Feb 16, 2025 | Fauchet Philippe | Director | Grant(A) | 15K | — | $0 |
| Feb 16, 2025 | Elam Nevan C | CEO, Director | Grant(A) | 204K | — | $0 |
| Feb 16, 2025 | Elam Nevan C | CEO, Director | Grant(A) | 120K | — | $0 |
| Feb 16, 2025 | Roberts Brian Kenneth | Chief Medical Officer | Grant(A) | 77K | — | $0 |
| Feb 16, 2025 | Roberts Brian Kenneth | Chief Medical Officer | Grant(A) | 45K | — | $0 |
| Feb 16, 2025 | Kim Young-Jin | Director | Grant(A) | 26K | — | $0 |
| Feb 16, 2025 | Kim Young-Jin | Director | Grant(A) | 15K | — | $0 |
| Feb 16, 2025 | Kreher Nerissa | Director | Grant(A) | 26K | — | $0 |
| Feb 16, 2025 | Kreher Nerissa | Director | Grant(A) | 15K | — | $0 |
| Feb 16, 2025 | Evans Daron | CFO | Grant(A) | 77K | — | $0 |
| Feb 16, 2025 | Evans Daron | CFO | Grant(A) | 45K | — | $0 |
| Feb 16, 2025 | Labrucherie Gil M | Director | Grant(A) | 26K | — | $0 |
| Feb 16, 2025 | Labrucherie Gil M | Director | Grant(A) | 15K | — | $0 |
| Feb 16, 2025 | Hogenhuis Wladimir | Director | Grant(A) | 26K | — | $0 |
| Feb 16, 2025 | Hogenhuis Wladimir | Director | Grant(A) | 15K | — | $0 |
| Dec 18, 2024 | Evans Daron | CFO | Buy(P) | 10K | $4.29 | $43K |
| Dec 12, 2024 | Evans Daron | CFO | Buy(P) | 9K | $4.60 | $41K |
| Dec 9, 2024 | Evans Daron | CFO | Buy(P) | 11K | $5.04 | $53K |
| Sep 24, 2024 | Hogenhuis Wladimir | Director | Buy(P) | 4K | $4.70 | $20K |
| Sep 23, 2024 | Evans Daron | CFO | Grant(A) | 100K | — | $0 |
| Jun 25, 2024 | Kim Young-Jin | Director | Buy(P) | 1.3M | $4.00 | $5.0M |
| Jun 25, 2024 | Hogenhuis Wladimir | Director | Buy(P) | 5K | $4.15 | $20K |
| Jun 14, 2024 | Evans Daron | CFO | Buy(P) | 40K | $4.04 | $162K |
| Jun 14, 2024 | Roberts Brian Kenneth | Chief Medical Officer | Buy(P) | 3K | $3.91 | $12K |
| Jun 14, 2024 | Roberts Brian Kenneth | Chief Medical Officer | Buy(P) | 300 | $3.96 | $1K |
| Jun 14, 2024 | Roberts Brian Kenneth | Chief Medical Officer | Buy(P) | 4K | $3.91 | $16K |
| Jun 14, 2024 | Roberts Brian Kenneth | Chief Medical Officer | Buy(P) | 300 | $3.97 | $1K |
| May 29, 2024 | Evans Daron | CFO | Buy(P) | 451 | $3.50 | $2K |
| May 24, 2024 | Evans Daron | CFO | Buy(P) | 3K | $3.23 | $10K |
| May 23, 2024 | Evans Daron | CFO | Buy(P) | 58 | $2.85 | $165 |
| May 23, 2024 | Roberts Brian Kenneth | Chief Medical Officer | Buy(P) | 6K | $2.68 | $16K |
| May 23, 2024 | Roberts Brian Kenneth | Chief Medical Officer | Buy(P) | 2K | $2.72 | $4K |
| Mar 28, 2024 | Roberts Brian Kenneth | Chief Medical Officer | Buy(P) | 500 | $2.55 | $1K |
| Mar 15, 2024 | Evans Daron | CFO | Buy(P) | 20K | $1.69 | $34K |
| Mar 14, 2024 | Roberts Brian Kenneth | Chief Medical Officer | Buy(P) | 10K | $1.88 | $19K |
| Mar 8, 2024 | Evans Daron | CFO | Buy(P) | 50K | $1.93 | $97K |
| Mar 7, 2024 | Kim Young-Jin | Director | Buy(P) | 37K | $1.91 | $70K |
| Mar 7, 2024 | Roberts Brian Kenneth | Chief Medical Officer | Buy(P) | 500 | $1.85 | $925 |
| Feb 26, 2024 | Roberts Brian Kenneth | Chief Medical Officer | Buy(P) | 2K | $1.70 | $3K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).